CL Colgate-Palmolive Company
CL Colgate-Palmolive Company
Consumer Defensive · Household & Personal Products
Desk view
Market read
POC $84.36 · VWAP $86.35 · +9.0% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $29.7M sold last open-market sell Wallace Noel R.
Cluster CEO, Director sold $30.1M, Aug 6–7
Coverage
1 watchlist
CL Price Structure
Loading timeframes…
Peers
Every watchlist CL belongs to, members best 30-day change first — CL highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
Reported the quarter ending 2026-06-30: revenue $5.36B, diluted EPS $0.86, net income $693M (SEC filing). Across the print the stock moved -1.9% (close before → first close after).
full note →Against street estimates
How CL's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about CL from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 9 days ago · Oct 8
- Colgate-Palmolive Company (CL) Q2 FY2026 earnings call transcript
- Colgate Announces 2nd Quarter 2026 Results - Morningstar
- Colgate-Palmolive's 2026 1st Qtr Earnings | Colgate-Palmolive Company
- Colgate Announces 2nd Quarter 2026 Results
- Colgate-Palmolive Company (SWX:CL) Stock Price & Overview
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
CL research tape
18 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.